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The bovine papillomavirus E2 transactivator protein enhances the ability of the E1 protein to bind to the viral origin of
replication which contains an E1 binding site flanked by two E2 binding sites. To determine which regions and functions of
the E2 protein are important for this cooperative interaction, a series of mutated E2 proteins were assayed for their ability
to enhance E1 origin-specific binding. Cooperative origin binding required at least one E2 DNA binding site, an intact
functional E2 DNA binding domain, and an intact transactivation domain. The hinge region of the E2 proteins was dispensable
for this activity. To further examine the role of the E2 C-terminal domain, a series of chimeric proteins were generated that
substituted the yeast GAL4 DNA binding domain for the E2 DNA binding domain. These chimeric proteins were able to
cooperatively bind to a hybrid origin that contained GAL4 binding sites in place of the E2 binding sites. These studies
indicate that the E2 transactivation domain is sufficient for interaction with the E1 protein and that the E2 DNA binding
domain is required for interaction with origin DNA sequences. q 1996 Academic Press, Inc.
INTRODUCTION al., 1986) and in transient replication assays (Ustav and
Stenlund, 1991). The E2 protein appears to have several
Papillomaviruses induce squamous epithelial tumors roles in DNA replication. It can alleviate nucleosome-
of the skin, respiratory tract, and anogenital mucosas in mediated repression of DNA replication (Li and Botchan,
man and many other vertebrate animals. The papillo- 1994) and may interact with cellular replication proteins
maviruses contain small double-stranded circular ge- such as replication protein A (RPA) (Li and Botchan,
nomes that replicate in the nucleus of infected cells. In 1993). In addition, the E1 binding site in the replication
virally transformed rodent cells, bovine papillomavirus origin is flanked by two E2 binding sites and the E2
type 1 (BPV-1) replicates as a stable multicopy plasmid protein enhances the binding of E1 to this region (Ustav
by a random choice mechanism (Law et al., 1981; Gilbert et al., 1991, 1995; Spalholz et al., 1993; Seo et al., 1995;
and Cohen, 1987; Ravnan et al., 1992; Piirsoo et al., 1996). Yang et al., 1991). Cooperative origin binding of the E1–
Only the viral E1 and E2 proteins are required for tran- E2 complex requires an intact E2 binding site (Lusky et
sient BPV-1 replication while the remaining replication al., 1993; Spalholz et al., 1993; Ustav et al., 1995). In
proteins are provided by the host cell (Ustav and Sten- addition to being able to bind specifically to adjacent
lund, 1991). The E1 protein binds specifically to se- DNA motifs, the E1 and E2 proteins also form a tight
quences within the origin of replication (Wilson and complex (Mohr et al., 1990; Blitz and Laimins, 1991).
Ludes-meyer, 1991; Ustav et al., 1991; Yang et al., 1991) Therefore, it is likely that efficient formation of the replica-
and functions as an ATP-dependent helicase and un- tion preinitiation complex requires specific protein–pro-
winding enzyme (Seo et al., 1993; MacPherson et al., tein and protein–DNA interactions between the E1 and
1995; Yang et al., 1993). The protein encoded by the full- E2 proteins and their respective DNA binding motifs.
length E2 open reading frame was originally found to be The full-length papillomavirus E2 proteins share two
a transcriptional transactivator that binds as a dimer to relatively conserved domains; a sequence-specific DNA
a 12-bp palindromic sequence (ACCN6GGT), several cop- binding and dimerization domain encoded by the C-ter-
ies of which are found in the viral enhancer sequences minal 85 amino acids (Moskaluk and Bastia, 1989;
(Androphy et al., 1987; Moskaluk and Bastia, 1987). More McBride et al., 1989, 1988; Dostatni et al., 1988) and a
recent studies have shown that the full-length E2 protein transactivation domain encoded by the N-terminal 194
is also required for viral DNA replication, both in trans- amino acids (Giri and Yaniv, 1988; Haugen et al., 1988;
formed cells (DiMaio and Settleman, 1988; Rabson et McBride et al., 1989). These two domains are separated
by a nonconserved internal hinge region which varies in
length and in amino acid sequence (McBride et al., 1989;1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (301) 480-1560. E-mail: alison_mcbride@nih.gov. Giri and Yaniv, 1988). Analysis of mutations in the E2
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ORF which delete various regions of the E2 protein dem- PTZkzE21 – 250GAL41 – 147 , PTZkzE21 – 283GAL41 – 147 , and
pTZkzGAL41 – 147 .onstrate that, in most cases, an intact transactivation
domain and an intact DNA binding domain are required Plasmid p818 contains the replication origin (nucleo-
tides 7781–7946/1–83) cloned into the BamHI and Hin-for DNA replication (Winokur and McBride, 1992; Ustav
et al., 1991). dIII sites of Bluescript KS/ (Stratagene) and has been
described previously (Spalholz et al., 1993). AdditionalIn this study we have identified the regions and func-
tions of the E2 protein that are required for cooperative replication origins (nucleotides 7891–7946/1–31) were
generated in a similar fashion using PCR primers withorigin binding with the E1 protein. It has previously been
shown that the shorter repressor form of E2 (E2-TR, resi- mutations in E2 binding sites 11 (ACCGAAACCGGT to
CACGAAACCGAG) and/or 12 (AACGGTGATGGT todues 162–410) is unable to enhance binding of E1 to
the origin (Mohr et al., 1990) and several studies have TAGGGTGATGAG). Four origin sequences, wt11-ori-
wt12, mt11-ori-wt12, wt11-ori-mt12, and mt11-ori-mt12indicated that the N-terminal domains of the BPV-1 and
HPV-16 E2 proteins are important for protein–protein in- were amplified and cloned into pBluescript KS/. A repli-
cation origin in which E2 binding sites 11 and 12 wereteraction with the E1 protein (Benson and Howley, 1995;
Hibma et al., 1995; Piccini et al., 1995; Storey et al., 1995; replaced with GAL4 binding sites was generated by PCR;
oligonucleotide primers containing GAL4 sites (CCG-Brokaw et al., 1996). However, there has been no system-
atic study showing which domains of the E2 protein are GAGGACAGTACTCCGGG) were used to synthesize a
BPV-1 origin fragment containing nucleotides 7907–necessary or sufficient for cooperative origin binding with
the E1 protein. The study presented here demonstrates 7946/1–15 flanked by GAL4 sites. This fragment was
cloned in the BamHI and HindIII sites of pBluescript KS/that an intact transactivation domain and intact DNA
binding domain are required for cooperative origin bind- resulting in plasmid pKS/G-O-G (see Fig. 3). A corre-
sponding fragment containing the origin flanked by wild-ing. Moreover, the DNA binding domain of the BPV-1 E2
protein can be substituted with that of the heterologous type E2 binding sites (BPV-1 nucleotides 7894 to 29) was
also amplified and cloned into pKS/ to generate pKS/E-GAL4 protein. Thus, it appears that the E2 transactivation
domain is required for interaction with the E1 protein and O-E. The sequences of all PCR products were confirmed
by DNA sequence analysis.that the E2 DNA binding domain must bind DNA and
target the E2 protein to the viral origin.
Protein extracts and antisera
MATERIALS AND METHODS [35S]-labeled proteins were expressed from the plas-
mids described above using the TNT reticulocyte lysatePlasmids
system (Promega). An aliquot of lysate was analyzed by
The pTZ18R in vitro expression plasmids and the C59 SDS–polyacrylamide gel electrophoresis and the radio-
mammalian expression plasmids that express various labeled E1 and E2 proteins were quantitated using a
mutated E2 proteins with N-terminal truncations, C-termi- Phosphorimager (Molecular Dynamics). Values were cor-
nal truncations, and in-frame internal deletions have rected for the number of methionines in the polypeptides
been described previously (McBride et al., 1989; Winokur and the volume of lysate was adjusted using unpro-
and McBride, 1992). In vitro expression plasmids con- grammed lysate so that the concentration of E2 proteins
taining point mutations in the DNA binding domain, in each lysate was constant. E1-specific antiserum,
pTZE2R342K and pTZE2R344K , will be described elsewhere SSQN, and E2-specific antiserum, DTSW, have been de-
(Carruth and McBride, 1996). The in vitro expression plas- scribed previously (Spalholz et al., 1993; McBride et al.,
mid encoding the E1 protein, p1126, has been described 1988).
previously (Sarafi and McBride, 1995). Chimeric proteins
containing the E2 transactivation domain and portions of Transient expression assay
the E2 hinge region linked in-frame to the GAL4 DNA
Transfections were carried out using the calciumbinding domain were generated using PCR techniques.
phosphate technique as previously described (SpalholzA DNA fragment encoding GAL4 amino acids 1–147 was
et al., 1985). Briefly, CV-1 cells were cotransfected withgenerated from pMA424 (a yeast expression vector (Ma
0.3 mg wild-type C59E2 or C59kzE2-GAL4 DNAs and 2and Ptashne, 1987a)) with either DraII, StuI, KpnI, or
mg of pG5BCAT, a GAL4-responsive CAT reporter plas-BstE2 sites at the 5* end and a BstXI site at the 3* end.
mid (Lillie and Green, 1989). Cell lysates were preparedThe amplified fragments were cloned into the equivalent
24–48 hr later. CAT assays were carried out using equiv-sites in C59kzE2 (Winokur and McBride, 1992) to gen-
alent quantities of protein from each dish.erate C59kzE21 – 219GAL41 – 147 , C59kzE21 – 250GAL41 – 147 ,
C59kzE21 – 283GAL41 – 147 , and C59kzGAL41 – 147 . The latter Cooperative DNA binding assay
construct expresses only the GAL4 DNA binding domain.
The inserts were also cloned into the pTZkzE2 in vitro Cooperative DNA binding was measured using a
DNA – protein coimmunoprecipitation assay as de-expression vector to generate PTZkzE21 – 219GAL41 – 147 ,
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scribed previously (Sarafi and McBride, 1995). The 1993; Seo et al., 1995; Ustav et al., 1995). To analyze
which regions and functions of the E2 protein are im-DNA probe was generated by cleaving the KS//origin
plasmids described above with BamHI, HindIII, and portant for cooperative origin binding, a number of mu-
tated E2 proteins were analyzed for their ability to en-AflIII to release a 250-bp fragment containing the origin
and two larger fragments from the vector that served hance E1 origin binding. A previously described DNA –
protein coimmunoprecipitation assay was used to evalu-as controls for nonspecific binding. These fragments
were end-labeled with [32P]dCTP and the Klenow frag- ate cooperative binding to the origin (Spalholz et al., 1993;
Sarafi and McBride, 1995). Lysates containing E1 and E2ment of DNA polymerase.
In the binding reaction, 15 to 25 ml reticulocyte lysate proteins were generated by coupled in vitro transcription
and translation. The E1 protein lysate was added to acontaining the E1 protein was added to a buffer con-
taining 10 mg sonicated salmon sperm DNA, 200 ng mixture of three labeled DNA fragments; the smallest
fragment contained the BPV-1 origin sequences (n7781–DNA probe, and a final concentration of 14 mM HEPES,
pH 7.4, 5 mM MgAc, 60 mM NaCl, 0.3 mM MgCl2 , 5% 7946/1–83) and the other two vector-derived fragments
served as controls for nonspecific binding. The DNA –glycerol, and 2.5 mM DTT in a total volume of 100 to
300 ml. Where indicated, 15 to 50 ml of reticulocyte protein complexes were immunoprecipitated with E1-
specific antiserum (SSQN) directed against the N-termi-lysate containing in vitro-translated E2 protein was
also added. This resulted in E1:E2 molar ratios of be- nus of the protein (amino acids 90 to 110) and the copre-
cipitated DNA present in the complexes was extractedtween 1:1 and 1:4. After 60 min incubation at room
temperature, protein A sepharose beads containing and analyzed by polyacrylamide gel electrophoresis. As
shown in Fig. 1A (lane 3), the E1 protein bound specifi-prebound affinity-purified SSQN antisera were added
to the binding reaction and incubated for 1 hr. Immune cally to the origin-containing fragment. When E2 protein
was added to the E1 lysate (lane 4), an E1-specific anti-complexes were washed three times in NT-100 (50 mM
Tris, pH 7.4, 100 mM NaCl, 0.1% Triton X-100). The sera immunoprecipitated approximately ninefold more of
the origin DNA fragment. Thus, as described previously,beads were suspended in 250 ml NT-200 and a 25-ml
aliquot was removed and analyzed for protein content the E2 protein enhanced the ability of E1 to bind the
replication origin (Ustav et al., 1991, 1995; Spalholz et al.,by SDS – polyacrylamide gel electrophoresis (data not
shown). The DNA – protein complexes on the beads 1993; Seo et al., 1995; Yang et al., 1991).
A variety of mutated E2 proteins were tested in thiswere dissociated with 1% SDS. Ten micrograms of car-
rier tRNA was added and DNA was isolated by phenol assay to determine which domains were required to en-
hance binding of the E1 protein to the origin. As shownextraction and ethanol precipitation. DNA fragments
were separated on polyacrylamide gels and were in Figs. 1A and 1B, all deletions that encroach on the
transactivation domain of E2 (E2D1 – 52 , E2-TR (162–410),quantitated using a Phosphorimager (Molecular Dy-
namics). E2D158 – 282 , E2D92 – 161 , and E2290 – 410) destroyed the ability
of the E2 proteins to enhance E1 origin binding, although
these E2 proteins could themselves still bind DNAE1-E2 interaction assay
(McBride et al., 1988). Therefore, the ability of the E2
A fragment of DNA containing six tandem E2 DNA protein to bind the E2 binding sites that flank the origin
binding sites was used as a probe for the E2 protein. of replication was not sufficient to stimulate E1 DNA
This 360-bp fragment was cleaved from pTKM-11 (Thierry binding and an intact transactivation domain was re-
et al., 1990) with EcoRI and HindIII and end-labeled with quired for this function. E2 proteins containing internal
[32P]dCTP and the Klenow fragment of DNA polymerase. in-frame deletions of the hinge region (amino acids 195
Twenty-five microliters of E1 reticulocyte lysate and 50 to 309) were able to efficiently enhance E1 origin-specific
ml E2 reticulocyte lysate were incubated with 200 ng DNA binding (see Fig. 1B), demonstrating that the E2 hinge
probe and 10 mg sonicated salmon sperm DNA in 33 region was not required for cooperative binding.
mM HEPES, pH 7.4, 150 mM NaCl, 70 mM MgAc, 0.27
mM MgCl2 , 4.5% glycerol, and 1.4 mM DTT. After 4 hr
E2 proteins defective for DNA binding cannotincubation at room temperature, the DNA–protein com-
stimulate binding of the E1 protein to the originplexes were immunoprecipitated and analyzed as de-
scribed above for the DNA binding assay. As shown in Fig. 1C, none of the C-terminally truncated
E2 proteins could enhance the ability of the E1 protein
RESULTS to bind the origin. Thus, an intact E2 DNA binding domain
is required for cooperative E1–E2 binding to the replica-Cooperative binding of E1 and mutated E2 proteins to
tion origin. To determine whether a functional C-terminalthe replication origin
domain is important for interaction with the E1 protein
and/or for interaction with the E2 binding sites of theThe E2 protein enhances binding of the E1 protein to
the origin of replication (Yang et al., 1991; Spalholz et al., replication origin, we assayed the ability of two E2 pro-
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FIG. 1. Cooperative binding of the E1 protein and mutated E2 proteins to the replication origin. (A, B, and C) The E2 proteins shown in the lower
diagrams were tested for cooperative origin binding with the E1 protein. In each case lane 1(M) contained 1 ng of input probe DNA and the DNA
fragment containing the origin is indicated with an arrow. In lanes 2 the assay contained 15 ml of lysate generated without the addition of exogenous
DNA. In the remaining lanes the assay contained 15 ml of wild-type or mutated in vitro-translated E2 proteins, as described above each lane. All
lanes except lanes 1 and 2 contained 15 ml of wild-type in vitro-translated E1 protein. In each case the DNA–protein complexes were immunoprecipi-
tated with the E1-specific antiserum, SSQN.
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FIG. 2. Interaction of mutated E2 proteins with the E1 protein. (A) Lane M contained 1 ng of input probe DNA and the fragment containing the
six E2 binding sites is indicated. Lanes 1 and 2 are controls showing the amount of this DNA fragment precipitated with an E1 antibody and no
E1 or E2 protein (lane 1) or E1 protein alone (lane 2). Lanes 3 to 15 show the amount of this fragment that is precipitated when either wild-type or
mutated E2 proteins are added. All DNA–protein complexes were immunoprecipitated with the E1-specific antibody, SSQN.
teins that were defective in DNA binding for their ability containing deletions in the N-terminus significantly di-
minished (E2D1 – 52 and E2D158 – 282) or abolished (E2-TR,to enhance E1-specific DNA binding. These proteins con-
tain conservative single amino acid substitutions in the E2290 – 410 , and E2D92 – 161) interaction with the E1 protein.
Mutations within the hinge region did not affect E1-E2DNA contact region of the DNA binding domain (R342K
and R344K) which abolish DNA binding but do not affect binding. These results suggest that an intact N-terminus
is required for both E1–E2 cooperative DNA binding andthe ability of the mutated proteins to form either homodi-
mers or heterodimers with the wild-type E2 protein (Car- for efficient E1–E2 protein interactions.
ruth and McBride, 1996). As shown in Fig. 1C (lanes 11
E2 DNA binding sites are required for cooperativeand 12), E2 proteins containing these mutations were
origin bindingunable to enhance binding of the E1 protein to the repli-
cation origin. These data indicate that the E2 proteins The BPV-1 genome contains seventeen E2 binding
must actually bind the origin DNA to enhance E1 binding. sites and two of these (sites 11 and 12) are situated
close to the E1 binding site in the replication origin (Li
The transactivation domain is required for interaction
et al., 1989) see Fig. 3). At least one E2 DNA binding site
with the E1 protein
is required for viral DNA replication (Ustav et al., 1995)
and, in gel shift assays, cooperative assembly of E1 andThese studies suggested that both the E2 transactiva-
tion and DNA binding/dimerization domains are im- E2 on the origin also requires a complete E2 binding site
12 (Lusky et al., 1993). To further examine the role of theportant for cooperative origin binding with the E1 protein.
Cooperative binding likely involves a combination of pro- E2 binding sites and to determine whether E1 and E2
proteins expressed in vitro require E2 binding sites intein–protein and protein–DNA interactions among the
E1 and E2 proteins and the origin region. To determine the replication origin for cooperative binding, several mu-
tated origins were generated as shown in Fig. 3. Thesewhich regions of the E2 protein are required for protein–
protein interaction with E1, a coprecipitation assay was origins contain mutations in either E2 binding site 11
and/or 12 but maintain the normal intervening origin se-used where the E1 and E2 proteins were mixed with 32P-
labeled DNA fragments; the smallest fragment contained quences.
The cooperative binding assay was carried out usingsix tandem E2 binding sites and no known E1 binding
site. DNA–protein complexes were immunoprecipitated the mutated origin fragments (Fig. 4). In each case, the E1
protein bound specifically to the smallest 90-bp fragmentwith E1-specific antibodies. If the E2 protein specifically
interacts with the E1 protein, then the E1 antibodies which contains the origin sequence depicted in Fig. 3.
When both E1 and E2 proteins were incubated with theshould coprecipitate the DNA fragment containing the
E2 DNA binding sites. This assay appeared to be more wild-type origin and immunoprecipitated with the E1-spe-
cific antisera, E1 origin binding was enhanced up to 20-specific than a coimmunoprecipitation assay, perhaps
because it selects for an interaction between two cor- fold. Origin fragments with mutations in either binding
site 11 or binding site 12 were also able to bind the E1rectly folded proteins. As shown in Fig. 2, E2 proteins
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FIG. 3. Sequence of the origin fragments. The region of the origin bound by the E1 protein (Ustav et al., 1991) is indicated. Wild-type or mutated
E2 binding sites and GAL4 binding sites are boxed.
protein and binding was enhanced by the addition of the E2 protein, forms dimers through the DNA binding do-
E2 protein (see Fig. 4). In this assay, E2 binding site 11 main. The first 147 amino acids of the protein constitute
appeared to be as effective as binding site 12 in enhanc- the DNA binding and dimerization domain (Ma and
ing the ability of E1 to bind to the origin. However, when Ptashne, 1987b; Keegan et al., 1986; Carey et al., 1989).
both E2 binding sites 11 and 12 were mutated, the E2 Three E2–GAL4 fusion proteins were generated that con-
protein did not enhance the ability of E1 to bind the origin. tained the amino terminal domain of E2 and different
Similar results were obtained when the E1–E2 com- lengths of the E2 hinge region fused in-frame to the GAL4
plexes were precipitated with antisera against the E2 DNA binding domain (E21–219GAL41–147 , E21–250GAL41–147 ,
protein. Wild-type E2 binding sites 11 and 12 have rela- and E21–283GAL41–147 , see Fig. 5A). The hinge region of
tively low affinity for the E2 protein with binding site 12 the E2 protein is thought to provide a spacer function to
having 10-fold lower affinity than binding site 11 (Li et increase flexibility between the transactivation and DNA
al., 1989). Consequently, binding of the E2 protein to the binding domains (Giri and Yaniv, 1988; McBride et al.,
flanking E2 binding sites could not always be detected 1989; Gauthier et al., 1991). Therefore, three different
when the immune complexes were immunoprecipitated lengths of hinge were included in the fusion proteins to
with E2-specific antisera, particularly when binding site increase the likelihood of producing stable and functional
11 was mutated. However, the addition of E1 protein proteins. The genes encoding these three E2–GAL4 fu-
greatly enhanced the amount of origin binding detected sion proteins and a control protein consisting of only the
with the E2-specific antisera, when at least one wild- GAL4 DNA binding domain were cloned into pTZkzE2,
type E2 DNA binding site was present. Thus, cooperative an in vitro expression vector, and into the C59kzE2 mam-
binding of the E1 and E2 proteins to the replication origin malian expression plasmid.
requires at least one E2 DNA binding site. Each chimeric protein was tested for functional integ-
rity by its ability to activate transcription from a GAL4-
The E2 DNA binding domain can be replaced with a responsive promoter in vivo. CV-1 cells were cotrans-
GAL4 DNA binding domain fected with the C59–E2–GAL4 expression plasmids and
pG5BCAT, a plasmid that expresses the chloramphenicolThese studies showed that the E2 protein required an
acetyl transferase (CAT) gene from a promoter that con-intact functional DNA binding domain to enhance binding
sists of 5 GAL4 binding sites upstream from the adenovi-of the E1 protein to the origin of replication. However, it
rus E1a TATA box (Lillie and Green, 1989). As shown inwas not clear whether the DNA binding domain in-
Fig. 5B, wild-type E2 and GAL41 – 147 control proteins werecreased E1–E2 origin binding by tethering the complex
unable to increase CAT expression from this plasmid.to the E2 binding site or whether the E2 DNA binding
However, each E2–GAL4 fusion protein was able to stim-domain had additional unique functions required for co-
ulate CAT activity by 7- to 11-fold. Thus, the E2–GAL4operative origin binding. For example, the E2 DNA bind-
fusion proteins produced are functionally active in thating domain could specifically interact with the E1 protein,
they were able to activate transcription from a GAL4-could affect the conformation of the amino-terminal E2
responsive plasmid.domain, or could specifically change the structure of the
To test the ability of the E2–GAL4 fusion proteins toorigin DNA to facilitate E1 binding. To further examine
cooperatively bind to the BPV-1 replication origin withthe function of the E2 DNA binding domain, a series of
the E1 protein, chimeric origins were generated that hadfusion proteins were generated in which the E2 DNA
GAL4 DNA binding sites in place of E2 binding sites 11binding domain was replaced by the GAL4 DNA binding
and 12 (GAL4-ori-GAL4, see Fig. 3). Both the E1 proteindomain. The yeast GAL4 protein is a well characterized
and the chimeric E2–GAL4 fusion proteins were able totranscriptional transactivator which has no intrinsic repli-
independently bind the chimeric origin fragment in thecation properties in other viral systems (Bennet-Cook and
Hassel, 1991; Gou and DePamphilis, 1992) and, like the DNA–protein immunoprecipitation assay (Fig. 6, left
AID VY 7989 / 6a19$$$181 05-30-96 16:46:27 vira AP: Virology
50 WINOKUR AND MCBRIDE
and GAL4 DNA binding domain proteins did not enhance
binding of E1 to the GAL4 binding site containing origin
(Fig. 6, left panel, lanes 3 and 7) and the E2–GAL4 fusion
proteins could not cooperatively bind an origin with wild-
type E2 binding sites (Fig. 6, right panel). These results
demonstrate that the DNA binding and dimerization func-
tions of the E2 C-terminal domain are required for E1–
E2 cooperative origin binding. However, these functions
can be performed by a heterologous DNA binding/dimer-
ization domain.
DISCUSSION
The BPV-1 E2 protein is required for viral DNA replica-
tion. It can form a complex with the E1 protein and en-
hances the interaction of the E1 protein with the replica-
tion origin. This study has demonstrated that two func-
tional domains of E2 are required for this property; the
N-terminal transactivation domain of the E2 protein is
important for complex formation with the E1 protein while
the C-terminal DNA binding/dimerization domain inter-
acts with the E2 DNA binding sites in the replication
origin. These results suggest a model whereby a combi-
nation of interactions among the proteins and DNA stabi-
lize the relatively weak DNA binding of the individual E1
and E2 proteins to their respective sites and allow a
stable and specific interaction of the E1/E2 complex with
the origin sequences.
The E2 transactivation domain is absolutely required
for transcriptional transactivation and for transient DNA
replication (McBride et al., 1989; Winokur and McBride,
1992). This study shows that, in addition, this domain is
critical for cooperative origin binding with the E1 protein
and for interaction with the E1 protein. Unlike many trans-
activation domains, the E2 N-terminal domain seems to
have a very constrained structure as any deletion that
has been made within this domain inactivates all E2-TA
functions, presumably by disrupting protein conformationFIG. 4. E2 binding sites are required for cooperative origin binding.
E2 binding sites 11 and 12 were mutated in an origin containing frag- (McBride et al., 1989; Winokur and McBride, 1992). This
ment as shown in Fig. 3. The E1 –E2 cooperative origin binding assay structural constraint may be due to the multifunctional
was carried out with each origin fragment which is indicated to the nature of the E2 protein. A recent study has shown that
right of each gel. In each case lane M contained 1 ng input DNA, the
single conservative point mutations within this domainassay in lanes 1 and 5 contained no E1 or E2 protein, lanes 2 and 6
can inactivate the E1 interaction properties of the E2contained E1 protein, lanes 3 and 7 contained E2 protein, and lanes
4 and 8 contained E1 and E2 proteins, as indicated at the top of protein but do not interfere with the transcriptional activa-
the figure. Lanes 1 to 4 were immunoprecipitated with an E1-specific tion function (Brokaw et al., 1996). In addition, it has also
antiserum (SSQN) and lanes 5 to 8 were immunoprecipitated with an been shown that the N-terminal 91 amino acids of BPV-
E2-specific antiserum (SRQE).
1 E2 are sufficient for interaction with the E1 protein in
the yeast two hybrid system (Benson and Howley, 1995)
and that a monoclonal antibody against amino acids 18panel, lane 2 and Fig. 6, middle panel, lanes 4–6). When
the E1 protein and individual E2–GAL4 fusion proteins to 41 of the HPV16 E2 protein can interfere with interac-
tion with the HPV16 E1 protein (Hibma et al., 1995).were mixed, in each case the E2–GAL4 fusion proteins
greatly enhanced binding of E1 to the chimeric origin The hinge region of the E2 protein is thought to form
a flexible spacer region between the transactivation and(Fig. 6, left panel, lanes 4–6). Notably, the E21–250GAL41–147
protein bound DNA less efficiently than the other two DNA binding domains. This study demonstrates that E2
proteins containing internal in-frame deletions of thefusion proteins (Fig. 6, center, lane 5) yet could still en-
hance E1 origin binding. As expected, the wild-type E2 hinge region (from amino acids 195 to 309) were able to
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FIG. 5. Activity of E2-GAL4 fusion proteins. (A) Diagram of structure of E2/GAL4 fusion proteins. (B) Transcriptional activation by the E2–GAL4
fusion proteins. CV1 cells were cotransfected with a GAL4-responsive CAT plasmid and the indicated E2/GAL4 expressing plasmids. Transactivation
activity is shown as % chloramphenicol acetylated.
efficiently enhance E1 origin-specific binding. Therefore, is absolutely required for DNA replication, some nonspe-
cific sequence is required to maintain the replicationthe E2 hinge region does not appear to be required for
cooperative binding. We have previously shown that, al- function. Two proteins with large deletions of the hinge
region (E2D220 – 309 and E2D213 – 309) are unable to promotethough no particular amino acid sequence of the hinge
FIG. 6. Cooperative origin binding of E1– and E2–GAL4 fusion proteins. The E1–E2 cooperative origin binding assay was carried out with the
E2 –GAL4 fusion proteins shown in Fig. 5. Either a wild-type origin (right panel) or an origin containing flanking GAL4 sites (left and middle panels)
was used to assay for E1–E2 cooperative binding. In each panel lane M contained 1 ng input DNA and lane 1 shows the result of the assay when
no E1 or E2 protein was added. In lanes 2 to 7 the assay contained E1 protein and in lanes 3 to 7 and 8 to 12 the assay contained either wild-
type or fusion E2 proteins (the proteins are labeled A to E as shown in Fig. 5A). DNA–protein complexes were immunoprecipitated with the E1-
specific antiserum, SSQN, in the left and right panels and with the E2-specific antiserum, DTSW, in the middle panel.
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